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Abstract
A prospective epidemiological study was conducted to evaluate the incidence of febrile cough episodes among adult Muslims travelling
from Marseille to Saudi Arabia during the Hajj pilgrimage and to assess if use of statin had an inﬂuence on this incidence. In total, 580
individuals were presented with a questionnaire. A signiﬁcant proportion of individuals had chronic medical disorders, e.g. diabetes mell-
itus (132, 22.8%) and hypertension (147, 25.3%). Pilgrims had a low level of education and a low employment rate. Sixty (10.3%) were
treated with statins for hypercholesterolemia. Four hundred and fourty-seven pilgrims were presented a questionnaire on returning
home. A total of 74 travellers (16.6%) experienced fever during their stay in Saudi Arabia (67 attended a doctor) and 271 (60.6%) had
cough (259 attended a doctor); 70 travellers with cough were febrile (25.9%). Seventy per cent of the travellers who suffered cough
episodes developed their ﬁrst symptoms within 3 days, suggesting a human to human transmission of the responsible pathogen, with
short incubation time as evidenced by a bimodal distribution of cough in two peaks at a 24 h interval. None of demographical and
socioeconomic characteristics, underlying diseases or vaccination against inﬂuenza signiﬁcantly affected the occurrence of cough. Diabe-
tes correlated with an increased risk of febrile cough (OR = 2.02 (1.05–3.89)) as well as unemployment (OR = 2.22 (0.91–5.53)). Use
of statins had no signiﬁcant inﬂuence on the occurrence of cough and/or fever during the pilgrimage. This result suggests that while
treatment with a statin has been demonstrated to reduce the mortality from severe sepsis associated with respiratory tract infections,
it probably does not play a role in the outcome of regular febrile cough episodes as observed in the cohort studied here.
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Introduction
Each year, approximately 2000 Muslims travel from Marseille
to participate in the Hajj, gathering with over two million
pilgrims from all over the world. Health risks during the Hajj
are a critical issue due to the extreme congestion of people
[1]. Infectious diseases represent a major problem during the
pilgrimage with acute respiratory infections (ARI) as the
most common cause of admission to hospital [2–4]. Hajj
pilgrims during their 1-month stay in Saudi Arabia experience
relatively homogeneous accommodation conditions, and
undertake identical rituals, while retracing the footsteps of
the Prophet Mohammed, thus being very likely exposed to
the same risk of ARI. In recent years, several non-random-
ized studies have linked statin use with decreased risk of
severe sepsis or death from severe infections, including
pneumonia [5–7]. Recent prospective cohort studies con-
ﬁrmed previous observations [8–12] while another suggested
that the apparent beneﬁcial effect of statins probably
reﬂected a ‘healthy user’ effect, as statin users appeared to
be younger, healthier, better educated, and socially and eco-
nomically more privileged compared to non-statin users [13].
These controversial ﬁndings also raised questions about the
potential role of statins in the prophylaxis of infectious dis-
eases such as pandemic inﬂuenza [14]. Muslims departing
from Marseille to participate in the Hajj have been found to
have a median age of 61 years, with more than one third
being over 64 years old [15], and are therefore likely to use
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statins in a signiﬁcant proportion. We conducted a
prospective epidemiological study to evaluate the incidence
of febrile cough episodes among Hajj pilgrims from Marseille
and to assess if statin use could have an inﬂuence on this
incidence. The socio-economic situation and health charac-
teristics of the travellers were not consistent with the
hypothesis of a ‘healthy user’ effect.
Materials and Methods
Study population
A prospective cohort study was carried out in the Marseille
Travel Medicine Centre (Hoˆpital Nord) from 4 November
to 8 December 2006. Participants in the survey were
pilgrims in preparation for the Hajj pilgrimage enrolled in the
meningococcal vaccination campaign to satisfy compulsory
vaccination requirements. Pilgrims older than 18 years were
included on a voluntary basis and participants were asked to
give written consent. Pre-travel questionnaires were pre-
sented orally, before vaccination, in French, in Arabic or in
French and Arabic, depending on the language ﬂuency level
of the participants. Post-travel questionnaires were pre-
sented by telephone.
Questionnaires
The pre-travel questionnaire included demographic factors
(age, gender, location of residence), indicators of immigration
status (country of birth and duration of stay in France),
socio-economic indicators (level of education, employment,
type of housing, rooms per person and household, comple-
mentary health insurance modalities), health status indicators
(diabetes, hypertension, chronic respiratory diseases, statin
use, vaccination coverage against inﬂuenza) and number of
previous travels to Saudi Arabia.
The post-travel questionnaire included travel indicators
(duration of stay, food and housing conditions) and data
about travel-associated diseases (medical consultation, hospi-
talization, occurrence of cough with or without fever, time
of manifestation and duration of symptoms). Cough was
deﬁned as occurrence of cough with or without sputum in
an individual without chronic cough and subjective aggrava-
tion of cough in individuals suffering from chronic respiratory
diseases. Fever was deﬁned as subjective feeling of fever. Pil-
grims were considered as lost in follow up after three failed
attempts to reach them by phone.
Analysis
Data were recorded anonymously in a Microsoft Access
database and transferred to EPIINFO 6.0 software (CDC,
Atlanta, GA, USA) for univariate statistic analysis. Differences
in proportions were evaluated using the chi-square test. As
selection procedure, a two-tailed p value £0.25 was consid-
ered as signiﬁcant [16]. Multivariate analysis was performed
using the SPSS version 15 software program (SPSS, Inc., Chi-
cago, IL, USA). Factors with a p value <0.25 in univariate
models were included in a multivariate model, as suggested
in the classical work of Mickey and Greenland [16]. Sex, age
and statin use were also included in the model. A stepwise
procedure based on likelihood ratio criteria was used in
order to obtain the best criteria with the lowest Akaike cri-
teria (AIC) [17–19]. For the ﬁnal model, a two-tailed p
value £0.05 was considered as signiﬁcant.
Results
Among 650 vaccinees preparing for the Hajj pilgrimage, 580
voluntarily participated in the study, yielding a response rate
of 89.2%.
Respondents had an average age of 58 years (range 20–85
years) with a sex ratio (M/F) of 1.32 (Table 1). A total of
217 travellers were living in Marseille (37.4%), 357 in other
parts of southern France (61.6%); information was not avail-
able in six cases (1.0%). Most of the pilgrims were born out-
side of France, with 88.8% having been born in North Africa.
The mean duration of stay in France was 32 years (range 0–72
years). A proportion of 83.1% of travellers had a primary
school education or below. Thirty-four per cent of individuals
were retired.
Among those under 65 years which is the age of retire-
ment in France, only 10.9% were employed. A proportion of
47.1% was living in state-subsidized housing and 49% received
state subsidies for payment of rent. Only 19.8% were prop-
erty owners. Among 41.2% of individuals, the household allo-
cation was less than one room per person. A proportion of
26.6% of travellers was covered by the state-ﬁnanced com-
plementary health insurance which is accessible to insolvent
individuals and 45.2% had a self-ﬁnanced private complemen-
tary health insurance.
A proportion of 7.4% were covered under the state-
ﬁnanced full health insurance coverage in cases of chronic
and debilitating disease. Forty-three per cent of the pilgrims
declared to suffer from chronic diseases, including 22.8%
suffering from diabetes, 25.3% from hypertension and 4.0%
from chronic respiratory disease. A proportion of 10.3% was
treated with statin for hypercholesterolaemia. A proportion
of 34.3% of travellers reported to have been vaccinated
against inﬂuenza in 2006. A total of 414 individuals (71.4%)
had never travelled to Saudi Arabia, 89 (15.3%) had made a
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previous pilgrimage to Mecca and 77 (13.3%) had travelled
several times to Saudi Arabia before.
A total of 447 pilgrims (77.1%) were presented a
questionnaire upon returning home, six individuals renounced
travel (1.0%) and the remaining (21.9%) were lost to follow-
up. The mean time between return and presentation of the
questionnaire was 27 days (range 1–98 days). No signiﬁcant
variation was observed between the 447 travellers who
answered the questionnaire and the 580 enrolled pilgrims
regarding demographic, immigration and socio-economic char-
acteristics, as well as underlying chronic diseases.
The mean duration of the pilgrimage was 30 days (range
14–63 days). The vast majority of pilgrims declared to have
been housed and to have eaten together (99.8% and 96.4%,
respectively). As shown in Table 2, a proportion of 53.9% of
travellers attended a doctor during travel and 6.5% did so
after travel. Nine individuals were hospitalized (two in Saudi
Arabia, one in Algeria and six upon returning to France).
Among the six patients hospitalized in France, two had a
respiratory tract infection. Haemophilus inﬂuenzae was identi-
ﬁed as the responsible pathogen in one of these two patients
who was also suffering from diabetes. Among the four other
hospitalized patients, two had unstable diabetes mellitus and
two had haematological disorders. A total of 74 travellers
(16.6%) experienced fever during their stay in Saudi Arabia
(67 attended a doctor) and 271 (60.6%) had cough (259
attended a doctor). Just over 25% of the travellers with
cough were febrile. Dates of beginning of fever and cough
are shown in Fig. 1. A ﬁrst peak was observed on 28
December, followed by a second peak on 30 December. The
mean duration of fever was 3 days (range 1–15 days) while
the mean duration of cough was 11 days (range 2–30 days).
TABLE 2. Travel-related diseases in 447 Hajj pilgrims
returning from Saudi Arabia
Variables Number (%)
Medical consultation
After travel 29 (6.5)
During travel 241 (53.9)
Symptoms during travel
Fever 74 (16.6)
Cough 271 (60.6)
Cough and fever 62 (13.9)
Reason for attending a doctor during travel (n = 270)
Fever 70 (25.9)
Cough 259 (95.9)
Rhinitis 9 (3.3)
Skin infection 1 (0.4)
Urinary tract infection 1 (0.4)
Other 6 (2.2)
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FIG. 1. Occurrence of cough and fever in Hajj pilgrims (number of
cases as expressed by date of ﬁrst symptoms).
TABLE 1. Demographics, immigration status and socio-
economic indicators in 580 Hajj pilgrims departing from
Marseille
Variables Number (%)
Age class
20–44 years 80 (13.8)
45–64 years 295 (50.9)
‡65 years 205 (35.3)
Gender
Male 330 (56.9)
Female 250 (43.1)
Location of residence
Marseille 217 (37.4)
South France (out of Marseille) 357 (61.6)
Unknown 6 (1.1)
Country of birth
Algeria 269 (46.4)
Morocco 149 (25.7)
Tunisia 97 (16.7)
France 37 (6.4)
Comoros 11 (1.9)
Other 17 (2.9)
Duration of stay in Francea
0–10 years 56 (10.4)
11–30 years 157 (20.0)
‡31 years 328 (60.6)
Education level
<CS 398 (68.6)
CS 84 (14.5)
Bac 20 (3.4)
>Bac 56 (9.7)
Employment
Retired 200 (34.5)
Employed 63 (10.9)
Non employed 263 (45.3)
Unknown 54 (9.3)
Type of housing
Shelter 29 (5)
Social housing 273 (47.1)
Renter of property 125 (21.6)
Owner of property 115 (19.8)
Other 38 (6.5)
Household rooms per person
<1 239 (41.2)
‡1 299 (51.6)
National subsidies for payment of rent
Yes 284 (49.0)
No 240 (41.4)
Complementary health care insurance modalities (CHI)
State-ﬁnanced CHI 154 (26.6)
Self-ﬁnanced private CHI 262 (45.2)
No CHI 121 (20.9)
FHIC 43 (7.4)
CS, certiﬁcate of study (primary school); Bac, baccalaureate; FHIC, state-
ﬁnanced full health insurance coverage due to suffering a chronic and debilitating
disease.
aImmigrants only.
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None of demographical and socio-economic characteris-
tics of pilgrims signiﬁcantly affected the occurrence of cough.
Similarly, previous travel to Saudi Arabia, diabetes, hyperten-
sion and chronic respiratory diseases, as well as vaccination
against inﬂuenza had no signiﬁcant inﬂuence on the occur-
rence of cough during the pilgrimage (Table 3). When con-
sidering only the cases of cough associated with fever,
travellers with diabetes appeared to have an increased risk
compared to other patients in univariate analysis (OR = 2.02
(1.1–3.7), p 0.02). Similarly, individuals of <65 years and
unemployed had a greater risk of cough associated with
fever (OR = 2.22 (0.98–5.03), p 0.05). Several factors
appeared to be related to febrile cough, without reaching
statistical signiﬁcance. None of the other factors inﬂuenced
the risk of febrile cough (Table 3). When adjusting factors
for multivariate analyses, only diabetes remained associated
with a higher risk of febrile cough (OR = 2.85 (1.37–5.92), p
0.005).
Statin users were signiﬁcantly older compared to other
travellers (mean age = 62.7 years, range 28–85 years vs.
55.7 years, range 23–78; p 0.004). However, sex ratio (1.00
vs. 0.75), education level £ certiﬁcate of primary school
study (93.2% vs. 85.6%), employment rate among individuals
under 65 years (9.7% vs. 20.3%), household rooms per per-
son <1 (49.1% vs. 43.9%), national subsidies for rent payment
(58.9% vs. 53.6%) and state-ﬁnanced complementary health
care insurance (30.0% vs. 26.2%) were not statistically differ-
ent in statin users and non-users. Use of statin had no signiﬁ-
cant inﬂuence on the occurrence of cough and or fever
during the pilgrimage.
Discussion
In the present study, we observed that Hajj pilgrims from
Marseille represent a speciﬁc population of travellers with
more than one third being geriatric patients, mainly originat-
ing from North Africa. This is consistent with previous ﬁnd-
ings [15]. Of particular concern was the ﬁnding that a
signiﬁcant proportion of individuals had chronic medical dis-
orders, e.g. diabetes mellitus and hypertension. Similarly, high
rates of diabetes and hypertension were found in patients
TABLE 3. Risk factors among travellers with cough and fever
Variables
Travellers without
cough and fever
(n = 176)
Travellers with
cough, non-febrile
(n = 201)
Univariate analysis
(travellers with cough
non-febrile versus
travellers without cough
and fever)
Travellers with
cough and fever
(n = 70)
Univariate analysis
(travellers with cough
and fever versus travel-
lers without cough and
fever)
OR (IC 95%) p OR (IC 95%) p
Age – mean (SD) 57.1 (12.8) 57.9 (11.7) – 0.51 57.7 (12.3) 1.00 (0.98–1.02) 0.74
Sex – number (incidence rate %)
Male 94 110 (53.9) 0.95 (0.62–1.46) 0.79 38 (28.8) 0.97 (0.69–1.53) 0.90
Female 82 91 (52.6) 32 (28.1)
Education level £ CS
Yes 127 131 (50.8) 0.72 (0.45–1.15) 0.14 46 (26.6) 0.74 (0.39–1.41) 0.32
No 49 70 (58.8) 24 (32.9)
No Employmenta,
Yes 78 96 (55.2) 1.17 (0.66–2.08) 0.56 41 (34.5) 2.22 (0.98–5.03) 0.05
No 38 40 (51.3) 9 (19.1)
Household rooms per person <1*
Yes 72 87 (54.7) 1.01 (0.64–1.57) 0.98 29 (28.7) 0.97 (0.54–1.73) 0.91
No 89 107 (54.6) 37 (29.4)
Previous travel to Saudi Arabia*
No 122 148 (54.8) 1.26 (0.78–2.03) 0.31 50 (29.1) 1.17 (0.63–2.16) 0.63
Yes 54 52 (49.1) 19 (26.0)
Diabetes
Yes 38 44 (53.7) 1.02 (0.60–1.72) 0.94 25 (39.7) 2.02 (1.1–3.7) 0.02
No 138 157 (53.2) 45 (24.6)
Chronic respiratory disease
Yes 9 6 (40.0) 0.94 (0.57–1.55) 0.79 4 (21.1) 1.13 (0.34–3.78) 0.85
No 167 195 (53.9) 66 (15.4)
Hypertension
Yes 43 51 (54.3) 1.05 (0.64–1.73) 0.83 20 (31.7) 1.24 (0.66–2.3) 0.50
No 133 150 (53.0) 50 (27.3)
Statin use
No 157 181 (53.6) 1.10 (0.53–2.25) 0.79 61 (28.0) 0.82 (0.35–1.91) 0.65
Yes 19 20 (51.3) 9 (32.1)
Vaccination against inﬂuenza
No 119 122 (50.6) 0.67 (0.42–1.07) 0.07 45 (27.4) 0.79 (0.43–1.43) 0.43
Yes 50 76 (60.3) 24 (32.4)
CS, certiﬁcate of study (primary school).
aEmployment rate in individual under 65 years only (%).
*Missing data.
Variables entered in the multivariate model.
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requiring admission to tertiary-care hospitals during the
Muslim pilgrimage [20]. We also observed that the level of
education of Hajj pilgrims was particularly low, with a
proportion of 83.1% of individuals with a level of education
below that of a certiﬁcate of primary school education com-
pared to 42.3% in the total immigrant population and 24.1%
in the general population of south eastern France (PACA)
[21]. The pilgrim employment rate was seven-times lower
and the proportion of pilgrims living in social housing in
state-owned property was twice that of the total immigrant
population in the same region [21].
These results, together with an overall low rate of vacci-
nation against tetanus, diphtheria, poliomyelitis and inﬂuenza
[15], suggest that Hajj travellers departing from Marseille
represent a category of travellers particularly at risk for tra-
vel-related diseases and that their socio-economic conditions
should be considered during the pre-travel visit regarding
cost-effective vaccines.
In our survey, we observed a very high attack rate of
cough episodes (60%), higher than that described in other
studies. One study reported an incidence of ARI of 40%
within a group of pilgrims from Riyadh [22]. A study based
on clinical criteria of inﬂuenza-like illness among pilgrims
from Pakistan reported rates of 36% in inﬂuenza-vaccinated
pilgrims and 62% in pilgrims not vaccinated against inﬂuenza
[23]. Another study involving English pilgrims, based on
seroconversion rates, showed an attack rate of 30% among
the vaccinated and 41% among the non-vaccinated partici-
pants [24]. Finally, an ARI attack rate of 26% was recently
observed among medical team members treating pilgrims in
Saudi Hospitals [25]. Vaccination coverage against inﬂuenza
did not inﬂuence the occurrence of ARI in our experience,
which strongly suggests that inﬂuenza virus was not the
pathogen responsible for the observed symptoms. When
investigating the pathogens causing respiratory tract infec-
tions in hospitalized patients during the Hajj, H. inﬂuenzae,
Klebsiella pneumoniae and Streptococcus pneumoniae appeared
to be the most common pathogens (30%) in one study
[26], while Mycobacterium tuberculosis was the most com-
mon pathogen (20%) identiﬁed in a study on community-
acquired pneumonias during the 1994 Hajj [27]. Viral patho-
gens are also commonly identiﬁed during the Hajj, repre-
senting 11–20% of pathogens responsible for upper
respiratory tract infections in hospitalized pilgrims with
Inﬂuenza A and B virus, rhinovirus and adenovirus being
the most common [26–29].
Seventy per cent of the travellers who developed cough
episodes in our study developed their ﬁrst symptoms within
3 days, suggesting human to human transmission of the
responsible pathogen, with short incubation time as evi-
denced by the bimodal distribution of cough in two peaks at
a 24 h-interval.
Statin use in this study was not associated with a reduc-
tion in the occurrence of travel-associated infections during
the Hajj pilgrimage. Occurrence of cough episodes, duration
of cough and association with fever were similar in travellers
treated with statins and control travellers. To our knowl-
edge, this is the ﬁrst prospective study investigating a poten-
tial role of statins in the outcome of cough episodes in a
cohort of individuals exposed to the risk. This result suggests
that, while treatment with statin has been demonstrated to
reduce the mortality of severe sepsis associated with respira-
tory tract infections [5–7], it does not play a medically signif-
icant role in the outcome of regular cough episodes as
observed in the cohort studied here. However, the study
involved limited numbers of statin users so that no deﬁnitive
conclusions should be made.
In this study, we observed that statin users were older
compared to non-users, but the level of education and
socio-economic characteristics were similar in both groups.
None of the demographic and socio-economic characteristics
of travellers affected the incidence of febrile cough in our
experience. However, the study does not have the sufﬁcient
size for the examination of several risk factors, e.g. a chronic
respiratory condition. Diabetes mellitus appeared to be cor-
related with febrile cough in the cohort studied here. It
remains uncertain whether diabetes is an independent risk
factor for increased incidence or severity of common upper
or lower respiratory tract infections [30]; however infections
caused by certain micro-organisms (Staphylococcus aureus,
Gram-negative organisms and M. tuberculosis) occur with
increased frequency. Infections due to other micro-organisms
(S. pneumoniae and inﬂuenza virus) are associated with
increased mortality and morbidity [31].
Our study highlights the fact that respiratory tract
infections are very likely to occur during the Hajj pilgrimage
independently of vaccination coverage against inﬂuenza.
Overcrowding and continuous close contact, notably in the
desert plains of Mina and Arafat where accommodation in
collective tents is necessary, greatly increases the spread of
respiratory tract infections. Under these conditions a single
case of severe acute respiratory syndrome during the Hajj
may cause an epidemic of unprecedented scale. During
pre-Hajj consultation such an event should be considered
in counselling travellers. Hand disinfection with alcohol-based
scrubs should be recommended as it was proven to protect
from ARI development; it should be acceptable to most
pilgrims given the religious insistence on ritual purity before
the ﬁve daily prayers [32]. The Saudi Arabian Ministry of
Health has recommended that masks be used to minimise
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droplet spread [33]. However, regular use of surgical face-
masks was recently shown to offer no signiﬁcant protection
against ARI, and intermittent use of surgical-type masks is
associated with increased risk of infection [25]. Furthermore,
many Muslims consider covering of the face during the Hajj
to be prohibited; therefore general compliance with this
advice is unlikely. Vaccination against H. inﬂuenzae and Pneu-
mococcus should be recommended to travellers suffering
from chronic respiratory disease and diabetes mellitus condi-
tions. Vaccination against diphtheria, tetanus, poliomyelitis
and pertussis should be updated when required and vaccina-
tion against inﬂuenza systematically proposed.
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